📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: FocalRx

1.1 - Company Overview

FocalRx Logo

FocalRx

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of novel tissue-marking devices for surgery that mark the surgical site of tissue removal in 3D. Its BioZorb tissue marker is an implantable device placed by surgeons to delineate the site of tissue removal and help surgeons, radiation oncologists, and other clinicians clearly identify the surgical site.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to FocalRx

Attovia Therapeutics Logo

Attovia Therapeutics

HQ: United States Website
  • Description: Provider of a biologics platform and pipeline of biotherapeutics for immune-mediated diseases, featuring ATTOBODY to generate binders and biparatopic biologics as alternatives to IgG-based medicines; programs include ATTO-1310 (IL31), ATTO-002 (IL31 x IL13), ATTO-004 (novel GPCR), and ATTO-005 (IBD).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Attovia Therapeutics company profile →
Spirogen Logo

Spirogen

HQ: United Kingdom Website
  • Description: Provider of novel, sequence-selective DNA minor groove-binding molecules and proprietary pyrrolobenzodiazepine (PBD) technology, including PBD-based ADC payloads and PBD dimers that cross-link DNA to block replication and kill cancer stem cells. Offers licensing of PBD technology and research collaborations/partnerships to develop PBD-based ADCs designed to deliver potent anticancer agents to cancer cells for different cancer treatments.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Spirogen company profile →
VeriTeQ Logo

VeriTeQ

HQ: United States Website
  • Description: Provider of animal and emergency identification solutions, with products used around the world for pet identification via patented, FDA-approved implantable microchips, and for livestock identification and tracking using visual and RFID ear tags.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full VeriTeQ company profile →
Lytix Biopharma Logo

Lytix Biopharma

HQ: Norway Website
  • Description: Provider of anti-microbials and cancer therapeutics, developing LTX-315, an oncolytic peptide for the treatment of solid tumors, currently in Phase II clinical trials for basal cell carcinoma.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lytix Biopharma company profile →
NuCana Logo

NuCana

HQ: United Kingdom Website
  • Description: Provider of ProTide phosphoramidate chemistry technology transforming widely prescribed nucleoside analog chemotherapies into more effective and safer cancer medicines. Programs include NUC-3373 (5-FU) for colorectal and other solid tumors, NUC-7738 (cordycepin) for solid tumors and melanoma, and Acelarin/NUC-1031 (gemcitabine) for biliary tract, pancreatic, and ovarian cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NuCana company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for FocalRx

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to FocalRx

2.2 - Growth funds investing in similar companies to FocalRx

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for FocalRx

4.2 - Public trading comparable groups for FocalRx

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to FocalRx

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About FocalRx

What does FocalRx do?

FocalRx is a provider of novel tissue-marking devices for surgery that mark the surgical site of tissue removal in 3D. Its BioZorb tissue marker is an implantable device placed by surgeons to delineate the site of tissue removal and help surgeons, radiation oncologists, and other clinicians clearly identify the surgical site.

Who are FocalRx's competitors?

FocalRx's competitors and similar companies include Attovia Therapeutics, Spirogen, VeriTeQ, Lytix Biopharma, and NuCana.

Where is FocalRx headquartered?

FocalRx is headquartered in United States.

How many employees does FocalRx have?

FocalRx has 1,000 employees 🔒.

When was FocalRx founded?

FocalRx was founded in 2010 🔒.

What sector and industry vertical is FocalRx in?

FocalRx is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for FocalRx

Who are the top strategic acquirers in FocalRx's sector and industry

Top strategic M&A buyers and acquirers in FocalRx's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for FocalRx?

Top strategic M&A buyers groups and sectors for FocalRx include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in FocalRx's sector and industry vertical

Which are the top PE firms investing in FocalRx's sector and industry vertical?

Top PE firms investing in FocalRx's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in FocalRx's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in FocalRx's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in FocalRx's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to FocalRx include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in FocalRx's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for FocalRx?

The key public trading comparables and valuation benchmarks for FocalRx include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for FocalRx for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for FocalRx with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in FocalRx's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for FocalRx with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in FocalRx's' sector and industry vertical?

Access recent funding rounds and capital raises in FocalRx's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for FocalRx